Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for non-implantable pelvic floor electrical stimulators, effective May 15, 2026. Here's what billing teams need to do.
CMS updated its non-implantable pelvic floor electrical stimulator coverage policy — a change that directly affects urology, urogynecology, women's health, and physical therapy practices that bill Medicare for these devices. The policy does not list specific CPT or HCPCS codes in the data available at this time. What it does signal is a coverage position that your billing team needs to review before the effective date of May 15, 2026. If your practice treats Medicare patients for urinary incontinence or pelvic floor dysfunction, this change is on your radar now.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS |
| Policy | Non-Implantable Pelvic Floor Electrical Stimulator |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | Medium-High |
| Specialties Affected | Urology, Urogynecology, Pelvic Floor Physical Therapy, Women's Health, Geriatric Medicine |
| Key Action | Review medical necessity documentation and prior authorization workflows before May 15, 2026 |
CMS Non-Implantable Pelvic Floor Electrical Stimulator Coverage Criteria and Medical Necessity Requirements 2026
The CMS non-implantable pelvic floor electrical stimulator coverage policy governs whether Medicare will pay for home-use or clinical-use devices that deliver electrical stimulation to the pelvic floor muscles. These devices treat conditions like stress urinary incontinence, urge incontinence, mixed incontinence, and pelvic floor muscle weakness. CMS has historically taken a restrictive position on these devices — and this 2026 modification continues that pattern.
Under the Centers for Medicare & Medicaid Services framework, non-implantable pelvic floor electrical stimulators fall into the durable medical equipment category. That means DME billing rules apply, including documentation requirements, supplier standards, and in some cases, prior authorization. Your billing team should treat this as a DME claim from the start, not an outpatient procedure charge.
Medical necessity is the central issue with this device category. CMS requires documented evidence that conservative treatments have been tried and failed before a pelvic floor stimulator qualifies for coverage. "Conservative treatments" typically means pelvic floor muscle exercises, behavioral therapy, and where appropriate, pharmacological management. If that documentation isn't in the chart before you bill, expect a claim denial.
The prior authorization question is real for this device class. Certain Medicare Advantage plans require prior auth for pelvic floor stimulators even when traditional Medicare does not. If your patients are on Medicare Advantage, check each plan's prior authorization requirements separately — they vary. Don't assume that a traditional Medicare coverage determination applies to an MA plan.
Reimbursement for non-implantable pelvic floor electrical stimulators under Medicare has always been tied tightly to the HCPCS coding for the device and any related supplies. The specific codes that apply to your claim depend on whether the device is for home use, how it's dispensed, and which MAC processes your claims. Since this policy does not list specific codes in the available data, work directly with your MAC or a billing consultant to confirm current HCPCS assignments before May 15, 2026.
CMS Non-Implantable Pelvic Floor Electrical Stimulator Exclusions and Non-Covered Indications
CMS has a long track record of limiting coverage for pelvic floor electrical stimulation to specific, well-documented clinical scenarios. Conditions that fall outside the narrow covered indications will generate a claim denial — often automatically.
Non-covered indications typically include use for conditions that lack sufficient clinical evidence, use in patients who haven't completed a trial of conservative therapy, and devices used solely for sexual dysfunction or other non-incontinence purposes. CMS does not cover pelvic floor stimulation as a preventive treatment or for general pelvic rehabilitation without a documented underlying diagnosis.
Implantable sacral nerve stimulators are a completely separate category — don't confuse them with this coverage policy. This policy governs external, non-implantable devices only. If your team accidentally routes an implantable device claim under non-implantable billing guidelines, the denial will be fast and the appeal will be harder than it needs to be.
Investigational or experimental designations can also come into play here. If a device is used in a clinical trial context or for an indication not yet cleared by the FDA, CMS will not cover it under standard benefit rules. Coverage with Evidence Development (CED) pathways exist, but they require a separate process and don't apply to routine billing.
Coverage Indications at a Glance
Note: The policy data available at this time does not include specific indication-level criteria. The table below reflects CMS's historically documented coverage positions for non-implantable pelvic floor electrical stimulators. Verify against the full policy at app.payerpolicy.org/p/cms/231-v2 before billing.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Stress urinary incontinence — after failed conservative therapy | Covered (when criteria met) | Not specified in policy data | Documentation of prior conservative treatment required; medical necessity must be established |
| Urge urinary incontinence — after failed conservative therapy | Covered (when criteria met) | Not specified in policy data | Behavioral therapy trial must be documented |
| Mixed urinary incontinence | Covered (when criteria met) | Not specified in policy data | Both stress and urge components must be documented |
| Preventive pelvic floor strengthening (no incontinence diagnosis) | Not Covered | Not specified in policy data | No documented clinical indication supporting coverage |
| Sexual dysfunction without incontinence diagnosis | Not Covered | Not specified in policy data | Outside scope of this coverage policy |
| Investigational or trial use | Not Covered (standard benefit) | Not specified in policy data | CED pathway required if applicable |
| Pelvic pain — primary diagnosis | Not Covered | Not specified in policy data | Not a covered indication under this policy |
CMS Non-Implantable Pelvic Floor Electrical Stimulator Billing Guidelines and Action Items 2026
The effective date of May 15, 2026 is not far out. Here's what your billing team should do now.
| # | Action Item |
|---|---|
| 1 | Pull your non-implantable pelvic floor stimulator claims from the last 12 months. Identify your claim volume, denial rates, and the HCPCS codes your team currently uses. If you're seeing elevated denials in this category already, this policy modification may explain why — or it may make things worse. Either way, you need baseline data before you can measure the impact of the change. |
| 2 | Confirm your HCPCS codes with your MAC before May 15, 2026. The policy does not specify codes in the available data. Your Medicare Administrative Contractor is the authoritative source for which HCPCS codes apply to your specific device and dispensing scenario. Call them or check the applicable local coverage determination for your region. |
| 3 | Audit your medical necessity documentation templates. Every claim for a non-implantable pelvic floor electrical stimulator needs chart notes that document the diagnosis, the conservative therapy trial, and why the device is medically necessary. If your templates don't capture that sequence, fix them now — before the effective date, not after your first denial. |
| 4 | Check your Medicare Advantage patients separately. MA plans set their own prior authorization requirements. Pull your MA payer contracts and check each plan's non-implantable pelvic floor stimulator billing guidelines. Some plans mirror traditional Medicare; many don't. If prior auth is required and you don't get it, you absorb the write-off. |
| 5 | Update your ABN workflow for non-covered scenarios. If a patient's clinical picture doesn't meet medical necessity criteria — or if they want the device for a non-covered indication — issue an Advance Beneficiary Notice before dispensing. This protects your practice and gives the patient informed financial consent. An ABN won't prevent a denial, but it determines who absorbs the cost. |
| 6 | Talk to your compliance officer if this is a high-volume service line. If pelvic floor electrical stimulation represents significant revenue for your practice, loop in your compliance officer before May 15, 2026. A policy modification at CMS can trigger MAC-level audits for this code category. You want your documentation house in order before that happens, not during. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Non-Implantable Pelvic Floor Electrical Stimulators Under This CMS Policy
Important: The policy data available for this CMS modification does not list specific CPT, HCPCS, or ICD-10 codes. The codes section of this post cannot be completed with verified data at this time.
Do not use codes from a prior policy version or a different payer's policy for this device category. HCPCS codes for durable medical equipment, including pelvic floor electrical stimulators, are updated periodically, and the correct code depends on your specific device and clinical scenario.
How to Find the Correct Codes
Your best sources for verified codes under this policy:
- Your MAC's website — Search for local coverage determinations (LCDs) related to pelvic floor electrical stimulation or electrical stimulation for urinary incontinence. Your MAC publishes the applicable HCPCS codes alongside coverage criteria.
- The CMS DMEPOS fee schedule — For home-use devices billed as DME, the fee schedule lists the applicable HCPCS codes and reimbursement rates.
- The full policy record at app.payerpolicy.org/p/cms/231-v2 — Check for updated code tables as this policy version is fully published.
- Your billing consultant or RCM team — If you're uncertain which code maps to your device, get a second opinion before the effective date. A wrong HCPCS code on a DME claim isn't just a claim denial — it's a compliance risk.
We'll update this post with specific codes as the full policy data becomes available.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.